title: Neurokinin 3 Receptor-Expressing Neurons in the Median Preoptic Nucleus Modulate Heat-Dissipation Effectors in the Female Rat.
abstract: KNDy neurons facilitate tail skin vasodilation and modulate the effects of estradiol on thermoregulation. We hypothesize that KNDy neurons influence cutaneous vasodilation via projections to neurons in the median preoptic nucleus (MnPO) that express the neurokinin 3 receptor (NK3R). In support of this hypothesis, focal microinjections of senktide, an NK3R agonist, into the MnPO lowers core temperature (TCORE) in the female rat. To further study the role of MnPO NK3R neurons in thermoregulation, these neurons were specifically ablated using a conjugate of a selective NK3R agonist and saporin (NK3-SAP). NK3-SAP or blank-SAP (control) was injected into the MnPO/medial septum. Tail skin temperature (TSKIN) and TCORE were measured in ovariectomized rats exposed to 3 ambient temperatures (TAMBIENT) before and after estradiol-17β (E2) treatment. Before killing, we injected senktide (sc), monitored TCORE for 70 minutes, and harvested brains for Fos immunohistochemistry. Ablation of MnPO NK3R neurons lowered TSKIN at neutral and subneutral TAMBIENT regardless of E2 treatment. However, ablation did not prevent the effects of E2 on TCORE and TSKIN. In control rats, senktide injections induced hypothermia with numerous Fos-immunoreactive cells in the MnPO. In contrast, in NK3-SAP rats, senktide did not alter TCORE and minimal Fos-immunoreactive neurons were identified in the MnPO. These data show that NK3R neurons in the MnPO are required for the hypothermic effects of senktide but not for the E2 modulation of thermoregulation. The lower TSKIN in NK3-SAP-injected rats suggests that MnPO NK3R neurons, like KNDy neurons, facilitate cutaneous vasodilation, an important heat-dissipation effector.
authors.affiliation: Departments of Pathology (M.A.M.-S., S.J.K.-H., N.E.R.), Cellular and Molecular Medicine (N.T.M., N.E.R.), and Neurology (N.E.R.), and the Evelyn F. McKnight Brain Institute (N.E.R.), University of Arizona College of Medicine, Tucson, Arizona 85724.
authors.forename: Melinda A
authors.initials: MA
authors.lastname: Mittelman-Smith
authors.affiliation: Departments of Pathology (M.A.M.-S., S.J.K.-H., N.E.R.), Cellular and Molecular Medicine (N.T.M., N.E.R.), and Neurology (N.E.R.), and the Evelyn F. McKnight Brain Institute (N.E.R.), University of Arizona College of Medicine, Tucson, Arizona 85724.
authors.forename: Sally J
authors.initials: SJ
authors.lastname: Krajewski-Hall
authors.affiliation: Departments of Pathology (M.A.M.-S., S.J.K.-H., N.E.R.), Cellular and Molecular Medicine (N.T.M., N.E.R.), and Neurology (N.E.R.), and the Evelyn F. McKnight Brain Institute (N.E.R.), University of Arizona College of Medicine, Tucson, Arizona 85724.
authors.forename: Nathaniel T
authors.initials: NT
authors.lastname: McMullen
authors.affiliation: Departments of Pathology (M.A.M.-S., S.J.K.-H., N.E.R.), Cellular and Molecular Medicine (N.T.M., N.E.R.), and Neurology (N.E.R.), and the Evelyn F. McKnight Brain Institute (N.E.R.), University of Arizona College of Medicine, Tucson, Arizona 85724.
authors.forename: Naomi E
authors.initials: NE
authors.lastname: Rance
mesh_terms: D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000502:physiology; D001833:Body Temperature Regulation / Q000187:drug effects / Q000502:physiology*; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D019584:Hot Flashes / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology; D011301:Preoptic Area / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D018042:Receptors, Neurokinin-3 / Q000819:agonists / Q000502:physiology*; D012867:Skin; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology*
chemical_list: D004967:Estrogens; D010446:Peptide Fragments; D018042:Receptors, Neurokinin-3; C054724:senktide; D013373:Substance P; D004958:Estradiol
references.citation: Endocrinology. 2005 Mar;146(3):1179-91
references.pmid: 15604214
references.citation: J Neuroendocrinol. 2003 Aug;15(8):749-53
references.pmid: 12834435
references.citation: J Neuroendocrinol. 2004 Feb;16(2):146-53
references.pmid: 14764001
references.citation: Science. 1979 Aug 24;205(4408):823-5
references.pmid: 462193
references.citation: J Nutr. 2010 Jul;140(7):1380S-5S
references.pmid: 20505017
references.citation: Brain Res. 2010 Dec 10;1364:116-28
references.pmid: 20800582
references.citation: Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19846-51
references.pmid: 23150555
references.citation: Neuroscience. 1992 Nov;51(1):107-20
references.pmid: 1281522
references.citation: Exp Lung Res. 2010 Nov;36(9):509-21
references.pmid: 20939761
references.citation: J Neuroendocrinol. 2006 Jul;18(7):534-41
references.pmid: 16774502
references.citation: Adv Anat Embryol Cell Biol. 2003;172:III-XII, 1-122, back cover
references.pmid: 12901335
references.citation: Am J Physiol. 1994 Sep;267(3 Pt 2):R673-7
references.pmid: 8092310
references.citation: J Comp Neurol. 1996 Aug 26;372(3):395-414
references.pmid: 8873868
references.citation: J Neuroendocrinol. 2008 Dec;20(12):1376-81
references.pmid: 19094085
references.citation: Endocrinology. 2010 Mar;151(3):1187-93
references.pmid: 20051485
references.citation: Front Neurosci. 2015 Feb 10;9:29
references.pmid: 25713511
references.citation: J Neurosci. 2009 Jul 22;29(29):9390-5
references.pmid: 19625529
references.citation: J Comp Neurol. 2006 Oct 10;498(5):712-26
references.pmid: 16917850
references.citation: Pharmacol Rev. 2009 Sep;61(3):228-61
references.pmid: 19749171
references.citation: Trends Neurosci. 2005 Mar;28(3):152-7
references.pmid: 15749169
references.citation: Endocrinology. 2008 Sep;149(9):4387-95
references.pmid: 18511511
references.citation: J Clin Endocrinol Metab. 1999 Jun;84(6):2111-8
references.pmid: 10372719
references.citation: Nat Neurosci. 2007 Sep;10(9):1131-3
references.pmid: 17676060
references.citation: Endocrinology. 2011 Mar;152(3):1001-12
references.pmid: 21239443
references.citation: J Appl Physiol (1985). 2002 Jun;92(6):2667-79
references.pmid: 12015388
references.citation: Eur J Pharmacol. 1987 Apr 29;136(3):401-3
references.pmid: 3038572
references.citation: Endocrinology. 2012 Jun;153(6):2800-12
references.pmid: 22508514
references.citation: Peptides. 1986 Jan-Feb;7(1):155-9
references.pmid: 3520509
references.citation: Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):741-6
references.pmid: 9435263
references.citation: J Neurosci. 2002 Jun 1;22(11):4600-10
references.pmid: 12040067
references.citation: J Chem Neuroanat. 1997 Mar;12(3):183-9
references.pmid: 9141650
references.citation: Endocrinology. 2010 Aug;151(8):3479-89
references.pmid: 20501670
references.citation: Pharmacol Ther. 2011 Mar;129(3):241-59
references.pmid: 20970451
references.citation: Brain Res. 2007 Aug 8;1162:69-75
references.pmid: 17618605
references.citation: J Pharmacol Exp Ther. 1997 Apr;281(1):499-507
references.pmid: 9103537
references.citation: J Neurosci. 2009 Sep 23;29(38):11954-64
references.pmid: 19776281
references.citation: Neurosci Lett. 1994 Dec 5;182(2):193-6
references.pmid: 7715808
references.citation: Br J Pharmacol. 1988 Jun;94(2):285-7
references.pmid: 2456111
references.citation: Neuroscience. 1992 Nov;51(2):317-45
references.pmid: 1465196
references.citation: Endocrinology. 2010 Nov;151(11):5389-94
references.pmid: 20861232
references.citation: Brain Res. 1998 Jul 6;798(1-2):127-39
references.pmid: 9666101
references.citation: J Clin Endocrinol Metab. 2007 Jul;92(7):2744-50
references.pmid: 17488799
references.citation: Endocrinology. 1991 May;128(5):2239-47
references.pmid: 1708331
references.citation: Proc Natl Acad Sci U S A. 2010 May 11;107(19):8848-53
references.pmid: 20421477
references.citation: Behav Brain Res. 2013 Mar 15;241:56-61
references.pmid: 23219969
references.citation: Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):457-61
references.pmid: 15854158
references.citation: J Neurosci. 2009 Sep 23;29(38):11859-66
references.pmid: 19776272
references.citation: Peptides. 2009 Jan;30(1):111-22
references.pmid: 18614256
references.citation: Neuroendocrinology. 1994 Oct;60(4):337-45
references.pmid: 7529897
references.citation: Am J Hum Biol. 2001 Jul-Aug;13(4):453-64
references.pmid: 11400216
references.citation: Endocrinology. 2011 Jul;152(7):2750-9
references.pmid: 21521752
references.citation: Endocrinology. 2011 Dec;152(12):4894-905
references.pmid: 22028440
references.citation: Front Neuroendocrinol. 2013 Aug;34(3):211-27
references.pmid: 23872331
references.citation: Neuroendocrinology. 2014;100(2-3):141-52
references.pmid: 25247878
references.citation: J Comp Neurol. 2005 Aug 29;489(3):372-86
references.pmid: 16025449
references.citation: J Clin Endocrinol Metab. 1990 Jul;71(1):79-85
references.pmid: 2370302
references.citation: Neuroscience. 2010 Mar 17;166(2):680-97
references.pmid: 20038444
references.citation: Endocrinology. 2004 Feb;145(2):736-42
references.pmid: 14592957
references.citation: J Neuroendocrinol. 2013 May;25(5):488-96
references.pmid: 23331967
references.citation: Am J Physiol. 1993 Jun;264(6 Pt 2):R1200-5
references.pmid: 8322974
references.citation: Clin Obstet Gynecol. 2008 Sep;51(3):539-48
references.pmid: 18677148
references.citation: Endocrinology. 2007 Dec;148(12):5752-60
references.pmid: 17823266
references.citation: J Neurosci. 2010 Feb 24;30(8):3124-32
references.pmid: 20181609
references.citation: Endocrinology. 2011 Jun;152(6):2387-99
references.pmid: 21486932
references.citation: Sci Rep. 2015;5:8466
references.pmid: 25683060